1,060 results on '"Muyldermans, Serge"'
Search Results
2. Epitope mapping of nanobodies binding the Alzheimer’s disease receptor SORLA
3. Orally delivered single-domain antibodies against gastrointestinal pathogens
4. Broad protection against invasive fungal disease from a nanobody targeting the active site of fungal b‐1,3‐glucanosyltransferases
5. Nanobodies targeting ABCC3 for immunotargeted applications in glioblastoma
6. An overview on display systems (phage, bacterial, and yeast display) for production of anticancer antibodies; advantages and disadvantages
7. Nanobodies as binding-chaperones stabilize the recombinant Bombyx mori acetylcholinesterase and protect the enzyme activity in pesticide detection
8. Animal Immunization, in Vitro Display Technologies, and Machine Learning for Antibody Discovery
9. Towards a Wearable Feminine Hygiene Platform for Detection of Invasive Fungal Pathogens via Gold Nanoparticle Aggregation
10. Instant One-Pot Green Synthesis of Functional Ultra-Stable Gold Nanoparticles: Vaginal Candidiasis Point-of-Care Case Study
11. Structural basis of nanobody recognition of grapevine fanleaf virus and of virus resistance loss
12. Selection of specific nanobodies to develop an immuno-assay detecting Staphylococcus aureus in milk
13. Correction to: Llama peripheral B-cell populations producing conventional and heavy chain-only IgG subtypes are phenotypically indistinguishable but immunogenetically distinct
14. Cytoplasmic Expression of Nanobodies with Formylglycine Generating Enzyme Tag and Conversion to a Bio-Orthogonal Aldehyde Group
15. Nanobodies: From Serendipitous Discovery of Heavy Chain-Only Antibodies in Camelids to a Wide Range of Useful Applications
16. Broad Protection against Invasive Fungal Disease from a Nanobody Targeting the Active Site of Fungal β‐1,3‐Glucanosyltransferases.
17. Bibliometric and scientometric analysis of PSMA-targeted radiotheranostics: knowledge mapping and global standing.
18. Towards a Wearable Feminine Hygiene Platform for Detection of Invasive Fungal Pathogens via Gold Nanoparticle Aggregation.
19. AAV‐mediated delivery of an anti‐BACE1 VHH alleviates pathology in an Alzheimer's disease model
20. Reshaping nanobodies for affinity purification on protein a
21. Development of anti-matrix metalloproteinase-2 (MMP-2) nanobodies as potential therapeutic and diagnostic tools
22. Instant Candida albicans Detection Using Ultra-Stable Aptamer Conjugated Gold Nanoparticles
23. Structural Insights into Polymorphic ABO Glycan Binding by Helicobacter pylori
24. Development of Nanobodies against Mal de Río Cuarto virus major viroplasm protein P9-1 for diagnostic sandwich ELISA and immunodetection
25. The Therapeutic Potential of Nanobodies
26. An innovative approach in the detection of Toxocara canis excretory/secretory antigens using specific nanobodies
27. Camel-Derived Nanobodies as Potent Inhibitors of New Delhi Metallo-β-Lactamase-1 Enzyme.
28. PSMA-targeted radiotheranostics in modern nuclear medicine: then, now, and what of the future?
29. Pharmacokinetics of radiolabeled dimeric sdAbs constructs targeting human CD20
30. Llama peripheral B-cell populations producing conventional and heavy chain-only IgG subtypes are phenotypically indistinguishable but immunogenetically distinct
31. Structural evaluation of a nanobody targeting complement receptor Vsig4 and its cross reactivity
32. Limiting the protein corona: A successful strategy for in vivo active targeting of anti-HER2 nanobody-functionalized nanostars
33. Electrochemical detection of Toxocara canis excretory-secretory antigens in children from rural communities in Esmeraldas Province, Ecuador: association between active infection and high eosinophilia
34. Paradigm shift in the diagnosis of peste des petits ruminants: scoping review
35. Site-Selective Functionalization of Nanobodies Using Intein-Mediated Protein Ligation for Innovative Bioconjugation
36. Data from Theranostic Radiolabeled Anti-CD20 sdAb for Targeted Radionuclide Therapy of Non-Hodgkin Lymphoma
37. Table S4 from Theranostic Radiolabeled Anti-CD20 sdAb for Targeted Radionuclide Therapy of Non-Hodgkin Lymphoma
38. Figure S1 from Theranostic Radiolabeled Anti-CD20 sdAb for Targeted Radionuclide Therapy of Non-Hodgkin Lymphoma
39. Site-Specific Radioactive Labeling of Nanobodies
40. Soluble aggregates present in cerebrospinal fluid change in size and mechanism of toxicity during Alzheimer’s disease progression
41. Screening and epitope characterization of diagnostic nanobody against total and activated Bacteroides fragilis toxin
42. Monitoring liver macrophages using nanobodies targeting Vsig4: Concanavalin A induced acute hepatitis as paradigm
43. Inactivation of γ‐secretases leads to accumulation of substrates and non‐Alzheimer neurodegeneration
44. Molecular Imaging with Kupffer Cell-Targeting Nanobodies for Diagnosis and Prognosis in Mouse Models of Liver Pathogenesis
45. Nanoimmunoassay onto a screen printed electrode for HER2 breast cancer biomarker determination
46. Single Domain Antibody application in bacterial infection diagnosis and neutralization
47. Exploration of Specific Nanobodies As Immunological Reagents to Detect Milk Allergen of β-Lactoglobulin without Interference of Hydrolytic Peptides
48. Nanobodies for the Early Detection of Ovarian Cancer
49. Nanobodies, Single-Domain Antigen-Binding Fragments of Camelid Heavy-Chain Antibodies
50. Isolation of Antigen-Specific Nanobodies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.